Nitric oxide drives embryonic myogenesis in chicken through the upregulation of myogenic differentiation factors

Experimental Cell Research

Volumn 320, Issue 2, 2014, Pages 269-280

  Cazzato, Denise ^a   Assi, Emma ^a   Moscheni, Claudia ^a   Brunelli, Silvia ^b   De Palma, Clara ^a   Cervia, Davide ^a,c   Perrotta, Cristiana ^a,d   Clementi, Emilio ^a,d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF TUSCIA   (Italy)

^d SCIENTIFIC INSTITUTE   (Italy)

Author keywords

CGMP PKG; Chick embryo; Mef2c; Murine myoblasts; Muscle development; NOS I

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE G; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2A; MYOCYTE ENHANCER FACTOR 2C; MYOD1 PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR 5; MYOGENIN; MYOSIN I; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; IN VITRO STUDY; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

MURINAE; SPONDIAS PURPUREA;

1-[N-(2-AMINOETHYL)-N-(2-AMMONIOETHYL)AMINO]DIAZEN-1-IUM-1,2-DIOLATE, DMEM, DULBECCO'S MODIFIED EAGLE'S MEDIUM; 1H-[1,2,4]OXADIAZOLO[4,3-A]QUINOXALIN-1-ONE; CGMP; CGMP-DEPENDENT PROTEIN KINASE; CGMP/PKG; CHICK EMBRYO; CYCLIC GMP; DETA; FBS; FOETAL BOVINE SERUM; GAPDH; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HAMBURGER AND HAMILTON; HH; HORSERADISH-PEROXIDASE; HRP; MEF2; MEF2C; MRFS; MURINE MYOBLASTS; MUSCLE DEVELOPMENT; MYOCYTE ENHANCER FACTOR 2; MYOGENIC REGULATORY FACTORS; N(Ω)-PROPYL-L-ARGININE; NEURONAL NOS; NITRIC OXIDE; NO; NO SYNTHASES; NOS; NOS-I; NPLA; ODQ; PBS; PHOSPHATE BUFFERED SALINE; PKG; SDS; SGC; SODIUM DODECYL SULPHATE; SOLUBLE GUANYLATE CYCLASE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MUSCLE DEVELOPMENT; MYOGENIC REGULATORY FACTORS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; UP-REGULATION;

EID: 84890857610     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.11.006     Document Type: Article

References (70)

1. Hirst D.G., Robson T. Nitric oxide physiology and pathology. Methods Mol. Biol. 2011, 704:1-13.
2. Tsutsui M., Shimokawa H., Morishita T., Nakashima Y., Yanagihara N. Development of genetically engineered mice lacking all three nitric oxide synthases. J. Pharmacol. Sci. 2006, 102:147-154.
3. Kuzin B., Roberts I., Peunova N., Enikolopov G. Nitric oxide regulates cell proliferation during Drosophila development. Cell 1996, 87:639-649.
4. Schwarz K.R., Pires P.R., de Bem T.H., Adona P.R., Leal C.L. Consequences of nitric oxide synthase inhibition during bovine oocyte maturation on meiosis and embryo development. Reprod. Domest. Anim. 2010, 45:75-80.
5. Sengoku K., Takuma N., Horikawa M., Tsuchiya K., Komori H., Sharifa D., Tamate K., Ishikawa M. Requirement of nitric oxide for murine oocyte maturation, embryo development, and trophoblast outgrowth in vitro. Mol. Reprod. Dev. 2001, 58:262-268.
6. Vignini A., Turi A., Giannubilo S.R., Pescosolido D., Scognamiglio P., Zanconi S., Silvi C., Mazzanti L., Tranquilli A.L. Follicular fluid nitric oxide (NO) concentrations in stimulated cycles: the relationship to embryo grading. Arch. Gynecol. Obstet. 2008, 277:229-232.
7. Gouge R.C., Marshburn P., Gordon B.E., Nunley W., Huet-Hudson Y.M. Nitric oxide as a regulator of embryonic development. Biol. Reprod. 1998, 58:875-879.
8. Tiboni G.M., Clementini E. Teratological consequences of nitric oxide synthesis inhibition. Curr. Pharm. Des. 2004, 10:2759-2767.
9. Khan H., Kusakabe K.T., Wakitani S., Hiyama M., Takeshita A., Kiso Y. Expression and localization of NO synthase isoenzymes (iNOS and eNOS) in development of the rabbit placenta. J. Reprod. Dev. 2012, 58:231-236.
10. Teichert A.M., Scott J.A., Robb G.B., Zhou Y.Q., Zhu S.N., Lem M., Keightley A., Steer B.M., Schuh A.C., Adamson S.L., Cybulsky M.I., Marsden P.A. Endothelial nitric oxide synthase gene expression during murine embryogenesis: commencement of expression in the embryo occurs with the establishment of a unidirectional circulatory system. Circ. Res. 2008, 103:24-33.
11. Saura M., Tarin C., Zaragoza C. Recent insights into the implication of nitric oxide in osteoblast differentiation and proliferation during bone development. Sci. World J. 2010, 10:624-632.
12. Liu Y., Feng Q. NOing the heart: role of nitric oxide synthase-3 in heart development. Differentiation 2012, 84:54-61.
13. Bloch W., Addicks K., Hescheler J., Fleischmann B.K. Nitric oxide synthase expression and function in embryonic and adult cardiomyocytes. Microsc. Res. Tech. 2001, 55:259-269.
14. Sherman T.S., Chen Z., Yuhanna I.S., Lau K.S., Margraf L.R., Shaul P.W. Nitric oxide synthase isoform expression in the developing lung epithelium. Am. J. Physiol. 1999, 276:L383-L390.
15. Nachmany A., Gold V., Tsur A., Arad D., Weil M. Neural tube closure depends on nitric oxide synthase activity. J. Neurochem. 2006, 96:247-253.
16. Contestabile A. Role of nitric oxide in cerebellar development and function: focus on granule neurons. Cerebellum 2012, 11:50-61.
17. Ciani E., Severi S., Contestabile A., Bartesaghi R. Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation. J. Cell Sci. 2004, 117:4727-4737.
18. Traister A., Abashidze S., Gold V., Plachta N., Karchovsky E., Patel K., Weil M. Evidence that nitric oxide regulates cell-cycle progression in the developing chick neuroepithelium. Dev. Dyn. 2002, 225:271-276.
19. Traister A., Abashidze S., Gold V., Yairi R., Michael E., Plachta N., McKinnell I., Patel K., Fainsod A., Weil M. BMP controls nitric oxide-mediated regulation of cell numbers in the developing neural tube. Cell Death Differ. 2004, 11:832-841.
20. Plachta N., Traister A., Weil M. Nitric oxide is involved in establishing the balance between cell cycle progression and cell death in the developing neural tube. Exp. Cell Res. 2003, 288:354-362.
21. Alexander P.G., Chau L., Tuan R.S. Role of nitric oxide in chick embryonic organogenesis and dysmorphogenesis. Birth Defects Res. A Clin. Mol. Teratol. 2007, 79:581-594.
22. Puttmann B., Gerlach E.M., Kruger M., Blottner D. Neuromuscular contacts induce nitric oxide signals in skeletal myotubes in vitro. Neurosignals 2005, 14:85-95.
23. Arnhold S., When M., Labbe D., Andressen C., Addicks K. Transient expression of NOS-II during development of the murine enteric nervous system. J. Mol. Histol. 2004, 35:741-748.
24. Kots A.Y., Bian K., Murad F. Nitric oxide and cyclic GMP signaling pathway as a focus for drug development. Curr. Med. Chem. 2011, 18:3299-3305.
25. Bellamy T.C., Wood J., Garthwaite J. On the activation of soluble guanylyl cyclase by nitric oxide. Proc. Nat. Acad. Sci. U.S.A. 2002, 99:507-510.
26. Knowles R.G., Palacios M., Palmer R.M., Moncada S. Formation of nitric oxide from l-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Nat. Acad. Sci. U.S.A. 1989, 86:5159-5162.
27. Sharin V.G., Mujoo K., Kots A.Y., Martin E., Murad F., Sharina I.G. Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells. Stem Cells Dev. 2011, 20:1287-1293.
28. Friebe A., Mergia E., Dangel O., Lange A., Koesling D. Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc. Nat. Acad. Sci. U.S.A. 2007, 104:7699-7704.
29. Brand-Saberi B., Wilting J., Ebensperger C., Christ B. The formation of somite compartments in the avian embryo. Int. J. Dev. Biol. 1996, 40:411-420.
30. Perry R.L., Rudnick M.A. Molecular mechanisms regulating myogenic determination and differentiation. Front. Biosci. 2000, 5:D750-D767.
31. Stockdale F.E., Nikovits W., Christ B. Molecular and cellular biology of avian somite development. Dev. Dyn. 2000, 219:304-321.
32. Buckingham M., Bajard L., Chang T., Daubas P., Hadchouel J., Meilhac S., Montarras D., Rocancourt D., Relaix F. The formation of skeletal muscle: from somite to limb. J. Anat. 2003, 202:59-68.
33. Parker M.H., Seale P., Rudnicki M.A. Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat. Rev. Genet. 2003, 4:497-507.
34. Cohn R.D., Campbell K.P. Molecular basis of muscular dystrophies. Muscle Nerve 2000, 23:1456-1471.
35. Kobzik L., Reid M.B., Bredt D.S., Stamler J.S. Nitric oxide in skeletal muscle. Nature 1994, 372:546-548.
36. Anderson J.E., Vargas C. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment. Neuromuscul. Disord. 2003, 13:388-396.
37. Blottner D., Luck G. Nitric oxide synthase (NOS) in mouse skeletal muscle development and differentiated myoblasts. Cell Tissue Res. 1998, 292:293-302.
38. Peunova N., Scheinker V., Ravi K., Enikolopov G. Nitric oxide coordinates cell proliferation and cell movements during early development of Xenopus. Cell Cycle 2007, 6:3132-3144.
39. Hamburger V., Hamilton H.L. A series of normal stages in the development of the chick embryo. 1951. Dev. Dyn. 1992, 195:231-272.
40. De Angelis L., Borghi S., Melchionna R., Berghella L., Baccarani-Contri M., Parise F., Ferrari S., Cossu G. Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. Proc. Nat. Acad. Sci. U.S.A. 1998, 95:12358-12363.
41. Barsacchi R., Perrotta C., Bulotta S., Moncada S., Borgese N., Clementi E. Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3' kinase, and Akt. Mol. Pharmacol. 2003, 63:886-895.
42. Piestun Y., Harel M., Barak M., Yahav S., Halevy O. Thermal manipulations in late-term chick embryos have immediate and longer term effects on myoblast proliferation and skeletal muscle hypertrophy. J. Appl. Physiol. 2009, 106:233-240.
43. Schultheiss T.M., Xydas S., Lassar A.B. Induction of avian cardiac myogenesis by anterior endoderm. Development 1995, 121:4203-4214.
44. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods 2001, 25:402-408.
45. Cervia D., Martini D., Ristori C., Catalani E., Timperio A.M., Bagnoli P., Casini G. Modulation of the neuronal response to ischaemia by somatostatin analogues in wild-type and knock-out mouse retinas. J. Neurochem. 2008, 106:2224-2235.
46. Clementi E., Brown G.C., Feelisch M., Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Nat. Acad. Sci. U.S.A. 1998, 95:7631-7636.
47. Perrotta C., Bizzozero L., Falcone S., Rovere-Querini P., Prinetti A., Schuchman E.H., Sonnino S., Manfredi A.A., Clementi E. Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma. Cancer Res. 2007, 67:7559-7564.
48. De Palma C., Falcone S., Pisoni S., Cipolat S., Panzeri C., Pambianco S., Pisconti A., Allevi R., Bassi M.T., Cossu G., Pozzan T., Moncada S., Scorrano L., Brunelli S., Clementi E. Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation. Cell Death Differ. 2010, 17:1684-1696.
49. Stockdale F.E. Myogenic cell lineages. Dev. Biol. 1992, 154:284-298.
50. Zhang H.Q., Fast W., Marletta M.A., Martasek P., Silverman R.B. Potent and selective inhibition of neuronal nitric oxide synthase by Nomega-propyl-l-arginine. J. Med. Chem. 1997, 40:3869-3870.
51. Burt D.W. Chicken genome: current status and future opportunities. Genome Res. 2005, 15:1692-1698.
52. Antin P.B., Kaur S., Stanislaw S., Davey S., Konieczka J.H., Yatskievych T.A., Darnell D.K. Gallus expression in situ hybridization analysis: a chicken embryo gene expression database. Poult. Sci. 2007, 86:1472-1477.
53. Burkhardt M., Glazova M., Gambaryan S., Vollkommer T., Butt E., Bader B., Heermeier K., Lincoln T.M., Walter U., Palmetshofer A. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J. Biol. Chem. 2000, 275:33536-33541.
54. Zhao Y., Brandish P.E., Di Valentin M., Schelvis J.P., Babcock G.T., Marletta M.A. Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 2000, 39:10848-10854.
55. Potthoff M.J., Olson E.N. MEF2: a central regulator of diverse developmental programs. Development 2007, 134:4131-4140.
56. Hinits Y., Hughes S.M. Mef2s are required for thick filament formation in nascent muscle fibres. Development 2007, 134:2511-2519.
57. Al Madhoun A.S., Mehta V., Li G., Figeys D., Wiper-Bergeron N., Skerjanc I.S. Skeletal myosin light chain kinase regulates skeletal myogenesis by phosphorylation of MEF2C. EMBO J. 2011, 30:2477-2489.
58. Ma K., Chan J.K., Zhu G., Wu Z. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol. Cell. Biol. 2005, 25:3575-3582.
59. Danalache B.A., Paquin J., Donghao W., Grygorczyk R., Moore J.C., Mummery C.L., Gutkowska J., Jankowski M. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells 2007, 25:679-688.
60. Cho-Lim J.J., Caiozzo V.J., Tseng B.P., Giedzinski E., Baker M.J., Limoli C.L. Satellite cells say NO to radiation. Radiat. Res. 2011, 175:561-568.
61. Wang G., Burczynski F.J., Hasinoff B.B., Zhang K., Lu Q., Anderson J.E. Development of a nitric oxide-releasing analogue of the muscle relaxant guaifenesin for skeletal muscle satellite cell myogenesis. Mol. Pharm. 2009, 6:895-904.
62. Ji Z.X., Du C., Wu G.S., Li S.Y., An G.S., Yang Y.X., Jia R., Jia H.T., Ni J.H. Synergistic up-regulation of muscle LIM protein expression in C2C12 and NIH3T3 cells by myogenin and MEF2C. Mol. Genet. Genomics 2009, 281:1-10.
63. Stamler J.S., Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 2001, 81:209-237.
64. Wang T., Xie Z., Lu B. Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses. Nature 1995, 374:262-266.
65. Nisoli E., Falcone S., Tonello C., Cozzi V., Palomba L., Fiorani M., Pisconti A., Brunelli S., Cardile A., Francolini M., Cantoni O., Carruba M.O., Moncada S., Clementi E. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc. Nat. Acad. Sci. U.S.A. 2004, 101:16507-16512.
66. Anderson J.E. A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol. Biol. Cell 2000, 11:1859-1874.
67. Buono R., Vantaggiato C., Pisa V., Azzoni E., Bassi M.T., Brunelli S., Sciorati C., Clementi E. Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP. Stem Cells 2012, 30:197-209.
68. De Palma C., Clementi E. Nitric oxide in myogenesis and therapeutic muscle repair. Mol. Neurobiol. 2012, 46:682-692.
69. Colussi C., Mozzetta C., Gurtner A., Illi B., Rosati J., Straino S., Ragone G., Pescatori M., Zaccagnini G., Antonini A., Minetti G., Martelli F., Piaggio G., Gallinari P., Steinkuhler C., Clementi E., Dell'Aversana C., Altucci L., Mai A., Capogrossi M.C., Puri P.L., Gaetano C. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc. Nat. Acad. Sci. U.S.A. 2008, 105:19183-19187.
70. N. Cordani, V. Pisa, L. Pozzi, C. Sciorati, E. Clementi, Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation, Stem Cells (in press) http://dx.doi.org/10.1002/stem.1587.